[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550131":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":10,"responsibleParty":30,"collaborators":10,"id":32,"slug":33,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":37,"acronym":10,"eligibilityCriteria":38,"healthyVolunteers":34,"sex":39,"minAge":40,"maxAge":41,"enrollmentInfo":42,"targetDuration":10,"studyType":45,"phases":10,"briefSummary":46,"conditions":47,"keywords":10,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":10},{"fullName":5,"class":6},"Nanfang Hospital, Southern Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Duodenal carcinoma patients",null,"The patients included in this study were drawn from a hospital-based cohort and included cases diagnosed and treated at the facility. Inclusion criteria were histologically confirmed non-ampulla DA, including all stages of disease at diagnosis. Patients were excluded if they had ampulla cancer or other forms of gastrointestinal cancer, had incomplete medical records, or lost follow-up shortly after diagnosis. This rigorous selection process ensured the homogeneity of the study population and the relevance of the findings to non-ampulla DA.",[13],"Procedure: Radical operation and perioperative therapy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Radical operation and perioperative therapy","Surgical intervention, particularly radical excision, was performed for each patient, including the extent of resection and lymph node dissection. Information on adjuvant therapies, such as chemotherapy and radiotherapy, was also recorded, specifying the regimens and durations.",[9],[21],{"name":22,"affiliation":23,"role":24},"Hao Liu, MD, PhD","Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China","PRINCIPAL_INVESTIGATOR",[26],{"name":22,"role":27,"phone":28,"phoneExt":10,"email":29},"CONTACT","+86-20-62787626","hao.liu@alumni.uni-heidelberg.de",{"type":31,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100550131","long-term-outcomes-of-duodenal-adenocarcinoma-from-a-large-cohort-100550131",false,"NCT06443086","Long-term Outcomes of Duodenal Adenocarcinoma From a Large Cohort","Long-term Survival Outcomes of Duodenal Adenocarcinoma: a Cohort Study With 15-year Single-center Experience","Inclusion criteria:\n\n(1) histologically confirmed non-ampulla DA;\n\nExclusion criteria:\n\n1. had other gastrointestinal cancer;\n2. had incomplete medical records, or lost follow-up shortly after diagnosis;\n3. refused clinical data collection.","ALL","18 Years","80 Years",{"count":43,"type":44},400,"ESTIMATED","OBSERVATIONAL","The investigators will conducted a hospital-based cohort study in our 15-year experience with DA aimed at investigating the long-term outcomes of the patients with DA, along with analyzing the impact of the tumor characteristics, operations and adjuvant therapy on survival outcomes.",[48],"Gastrointestinal Disease","NOT_YET_RECRUITING","2024-06-03",{"date":52,"type":53},"2024-06-05","ACTUAL",{"date":55,"type":44},"2024-06-15",{"date":57,"type":44},"2024-12-30",{"name":5,"class":6}]